Reducing Modifiable Risk Factors to Prevent and Control Non-Communicable Diseases: 2nd Edition

Dear Colleagues,

This Special Issue is the second edition of “Reducing Modifiable Risk Factors to Prevent and Control Non-Communicable Diseases” (https://www.mdpi.com/journal/jcm/special_issues/SWVY3375T7).

Non-communicable diseases (NCDs) represent the leading cause of mortality and morbidity worldwide, accounting for more than 70% of global deaths each year. These conditions, including cardiovascular diseases, cancers, chronic respiratory diseases, diabetes mellitus, and mental health disorders, are caused by a multifactorial interplay of genetic, metabolic, environmental, and behavioural factors.

The global burden of NCDs has increased steadily over recent decades, largely driven by ageing populations, urbanization, and lifestyle changes. Without effective preventive strategies, this trend is expected to continue, imposing substantial social, economic, and healthcare challenges across all countries, particularly in low- and middle-income regions.

Reducing exposure to modifiable risk factors such as tobacco use, physical inactivity, unhealthy diet, obesity, and harmful alcohol consumption represents a cornerstone of global efforts to prevent and control NCDs. Evidence-based public health interventions targeting these determinants can significantly decrease premature mortality and improve quality of life at the population level.

This Special Issue aims to provide a comprehensive and updated overview of advances in the prevention and management of non-communicable diseases through the reduction of modifiable risk factors. Building on the success of the first edition, this second edition specifically encourages submissions that leverage novel methodologies, including digital health tools, real-world data analytics, and implementation science frameworks, to evaluate the effectiveness and scalability of risk factor interventions. We welcome contributions from clinicians, clinical researchers, epidemiologists, and public health professionals working at the intersection of NCD prevention and clinical practice. Submissions may include original research articles, systematic reviews and meta-analyses, clinical studies, observational studies, intervention trials, and narrative reviews that provide evidence-based insights into risk factor modification and NCD control strategies. We look forward to receiving high-quality submissions that will contribute to strengthening the scientific basis for reducing the global burden of NCDs.

Dr. Daniele Piovani
Dr. Gisella Figlioli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.